Semaglutide is already well-known as a strong GLP-1 receptor agonist used for both diabetes and weight loss. However, tirzepatide’s dual-action mechanism gives it a distinct edge. In head-to-head studies, tirzepatide patients lost more weight and achieved better blood sugar control than those using semaglutide alone. https://biotechlabzsupply.com/